Legal Representation
Attorney
Michael H. Jacobs
USPTO Deadlines
Application History
38 events| Date | Code | Type | Description |
|---|---|---|---|
| Apr 2, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Apr 2, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Jan 3, 2025 | ALIE | A | ASSIGNED TO LIE |
| Jan 3, 2025 | CNFR | W | SU - FINAL REFUSAL - WRITTEN |
| Jan 3, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jan 3, 2025 | GNFR | O | FINAL REFUSAL E-MAILED |
| Jan 3, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Jan 3, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Nov 26, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Aug 29, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Aug 29, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Aug 29, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Aug 28, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 28, 2024 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Aug 28, 2024 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN |
| Jul 23, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Jul 23, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jul 23, 2024 | DPCC | D | DIVISIONAL PROCESSING COMPLETE |
| Jul 23, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jul 21, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jun 6, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Jun 6, 2024 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED |
| Jun 6, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 6, 2024 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jun 6, 2024 | IUAF | S | USE AMENDMENT FILED |
| Jun 6, 2024 | DRRR | I | DIVISIONAL REQUEST RECEIVED |
| Dec 12, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Oct 17, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Oct 17, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Sep 27, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sep 8, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 7, 2023 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Sep 7, 2023 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Sep 7, 2023 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Sep 7, 2023 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Sep 5, 2023 | DOCK | D | ASSIGNED TO EXAMINER |
| Feb 27, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Feb 10, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Providing medical and scientific research information in the field of pharmaceutical research
First Use Anywhere:
Feb 6, 2023
First Use in Commerce:
Feb 6, 2023
Class 044
Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing information in the field of treatment of neurological disorders and central nervous system disorders; consulting services in the field of pharmaceuticals
First Use Anywhere:
Feb 6, 2023
First Use in Commerce:
Feb 6, 2023
Classification
International Classes
042
044